The Protective Effect of a Unique Mix of Polyphenols and Micronutrients against Neurodegeneration Induced by an In Vitro Model of Parkinson's Disease.
Parkinson’s disease
SIRT1
inflammation
oxidative stress
polyphenols
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
13 Mar 2022
13 Mar 2022
Historique:
received:
22
02
2022
revised:
10
03
2022
accepted:
10
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
9
4
2022
Statut:
epublish
Résumé
Parkinson's disease (PD) is second-most common disabling neurological disorder worldwide, and unfortunately, there is not yet a definitive way to prevent it. Polyphenols have been widely shown protective efficacy against various PD symptoms. However, data on their effect on physio-pathological mechanisms underlying this disease are still lacking. In the present work, we evaluated the activity of a mixture of polyphenols and micronutrients, named A5
Identifiants
pubmed: 35328530
pii: ijms23063110
doi: 10.3390/ijms23063110
pmc: PMC8955775
pii:
doi:
Substances chimiques
Micronutrients
0
Polyphenols
0
Oxidopamine
8HW4YBZ748
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Arch Toxicol. 2018 Feb;92(2):669-677
pubmed: 28980048
Nutrients. 2018 May 19;10(5):
pubmed: 29783725
Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4):
pubmed: 28716886
Front Pharmacol. 2020 May 28;11:779
pubmed: 32547392
Parkinsons Dis. 2018 Sep 2;2018:9163040
pubmed: 30245802
J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76
pubmed: 18344392
FASEB J. 2009 Jun;23(6):1625-37
pubmed: 19141537
J Neural Transm (Vienna). 2000;107(3):281-93
pubmed: 10821437
J Immunol Methods. 2000 Sep 21;243(1-2):167-90
pubmed: 10986414
Front Neurosci. 2021 Mar 23;15:631501
pubmed: 33833662
J Cell Physiol. 2008 Jul;216(1):276-85
pubmed: 18270969
Neurochem Res. 2005 Mar;30(3):333-48
pubmed: 16018577
Clin Neurophysiol. 2008 Jul;119(7):1459-74
pubmed: 18467168
Eur J Pharmacol. 2008 Dec 14;600(1-3):78-82
pubmed: 18940189
Neurochem Int. 2020 Mar;134:104671
pubmed: 31926197
Lancet Neurol. 2009 Apr;8(4):382-97
pubmed: 19296921
Acta Med Iran. 2016 Aug;54(8):494-502
pubmed: 27701719
Front Neurol. 2018 Oct 15;9:860
pubmed: 30459700
J Neural Transm (Vienna). 2002 May;109(5-6):731-45
pubmed: 12111464
Naunyn Schmiedebergs Arch Pharmacol. 2018 Apr;391(4):445-453
pubmed: 29411055
Exp Gerontol. 2019 Sep;124:110653
pubmed: 31295526
Biomedicines. 2021 Nov 19;9(11):
pubmed: 34829949
Molecules. 2013 Nov 27;18(12):14726-38
pubmed: 24288000
J Basic Clin Physiol Pharmacol. 2020 Sep 14;32(2):11-17
pubmed: 32918805
Curr Pharm Des. 2021;27(34):3591-3601
pubmed: 33183192
Arch Biochem Biophys. 2011 Apr 1;508(1):1-12
pubmed: 21176768
Mol Neurodegener. 2015 Mar 02;10:4
pubmed: 26013581
Oxid Med Cell Longev. 2020 Aug 4;2020:3986348
pubmed: 32831997
Front Immunol. 2018 Nov 05;9:2527
pubmed: 30455692
Food Chem Toxicol. 2013 Feb;52:28-35
pubmed: 23137955
Subcell Biochem. 2012;65:389-455
pubmed: 23225012
J Pharm Pharmacol. 2015 May;67(5):720-30
pubmed: 25644078
Biofactors. 2017 Nov;43(6):760-769
pubmed: 28817221
Neurotox Res. 2012 Jan;21(1):128-41
pubmed: 22095091
Biomolecules. 2021 Apr 22;11(5):
pubmed: 33922207
Antioxidants (Basel). 2020 Apr 17;9(4):
pubmed: 32316601
Mol Med Rep. 2014 Nov;10(5):2223-33
pubmed: 25215472
Biofactors. 2018 Jan;44(1):16-25
pubmed: 29315886
Parkinsonism Relat Disord. 2007;13 Suppl 3:S450-6
pubmed: 18267282
Front Aging Neurosci. 2020 Apr 17;12:103
pubmed: 32362821
Chem Biol Interact. 2018 Jan 5;279:111-120
pubmed: 29054324
J Cell Biochem. 2018 Aug;119(8):7053-7062
pubmed: 29737568
Acta Neuropathol. 2009 Oct;118(4):541-52
pubmed: 19529948
Front Neurosci. 2018 Aug 30;12:612
pubmed: 30214392
J Child Neurol. 2003 Dec;18(12):851-66; discussion 867
pubmed: 14736079
Neurol Ther. 2018 Jun;7(1):5-11
pubmed: 29368093